🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to assess the efficacy of nimotuzuma...
Status
Completed
Location
Hospital Evangélico do Cachoeiro do Itapemirim
Start Date
2009-01
Trial ID
NCT01249352
Treatments Being Tested
Nimotuzumab (hR3) is an IgG1 humanized monoclonal antibody that recognized ...
Status
Withdrawn
Location
Cancer Institute & Hospital, Chinese Academy of Medical Sciences
Start Date
2009-09
Trial ID
NCT00985998
Treatments Being Tested
The purpose of this study is to define the response and toxicities with the...
Status
Completed
Location
National Cancer Center Singapore
Start Date
2008-04-28
Trial ID
NCT00702481
Treatments Being Tested
The aim of the study is to evaluate the role of nimotuzumab in the neo-adju...
Status
Completed
Location
Fudan University Cancer Hospital
Start Date
2009-05
Trial ID
NCT00910117
Treatments Being Tested
Nimotuzumab is an IgG1 humanized monoclonal antibody that recognized an epi...
Status
Unknown
Location
Sun Yat-Sen University Cancer Center
Start Date
2009-06
Trial ID
NCT00972465
Treatments Being Tested
This is a prospective, phase II, exploratory clinical trial. The study aim...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07388095
Treatments Being Tested
Esophageal cancer is one of common malignant tumors in China and esophageal...
Status
Withdrawn
Location
Beijing Cancer Hospital & Peking University Cancer Hospital
Start Date
2014-11
Trial ID
NCT02272699
Treatments Being Tested
There have been reports suggesting that anti-epidermal growth factor antibo...
Status
Withdrawn
Location
The first affiliated hospital, Zhejiang University
Start Date
2014-02
Trial ID
NCT02034968
Treatments Being Tested
The aim of the study is to improve the loco-regional control rate and overa...
Status
Unknown
Location
Flinders Medical Centre
Start Date
2009-08-13
Trial ID
NCT00957086
Treatments Being Tested
In order to evaluate the efficacy and safety of nimotuzumab combined with p...
Status
Recruiting
Location
National Sun Yat-sen University Cancer Center
Start Date
2024-08-01
Trial ID
NCT05978050
Treatments Being Tested